GregoryRichardson
2021-11-18

MRNA has almost SEVEN TIMES the market cap of Novavax.
Novavax is well on their way to approvals of their safe, effective, protein-based vaccine ALL AROUND THE WORLD. Including the EU very soon (where Moderna is slowly being disengaged).
NVAX has manufacturing capacity of more than 2Billion doses/year.
Now - which has more upside potential?
So you like Moderna - but why wouldn't you own both?

$Moderna, Inc.(MRNA)$ $Novavax(NVAX)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法